Adjuvant therapy with Sutent® extends disease-free survival in high risk renal cell carcinoma patients
Renal cell carcinoma (RCC) is one of the most common types of kidney cancer. It is diagnosed annually in...
FDA ALERT REGARDING RISKS ASSOCIATED WITH OVARIAN CANCER SCREENING TESTS
Ovarian cancer is the sixth most commonly diagnosed cancer worldwide. Second, only to uterine cancer, it is a leading...
First-line therapy with avelumab in patients with advanced NSCLC is found to have clinical activity
Lung cancer is the second most common cancer in both men and women (excluding skin cancer). It is the...